<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Park Medical Group</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+A86008">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Park Medical Group is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0501090S0&amp;denomIds=5.1.9&amp;selectedTab=summary">Rifampicin combined preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>2</td>&#13;
      <td>Antituberculosis drugs</td>&#13;
      <td>2</td>&#13;
      <td>1.00</td>&#13;
      <td>0.02</td>&#13;
      <td>0.12</td>&#13;
      <td>7.92</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0501090S0AAABAB&amp;denomIds=5.1.9&amp;selectedTab=summary" target="_blank">Rifampicin 300mg / Isoniazid 150mg tablets : 2</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0902011AA&amp;denomIds=9.2.1&amp;selectedTab=summary">Patiromer calcium</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Oral potassium</td>&#13;
      <td>2</td>&#13;
      <td>0.50</td>&#13;
      <td>0.01</td>&#13;
      <td>0.06</td>&#13;
      <td>7.78</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0902011AAAAABAB&amp;denomIds=9.2.1&amp;selectedTab=summary" target="_blank">Patiromer calcium 16.8g oral powder sachets : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0601023A0&amp;denomIds=6.1.2&amp;selectedTab=summary">Acarbose</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>20</td>&#13;
      <td>Other antidiabetic drugs</td>&#13;
      <td>523</td>&#13;
      <td>0.04</td>&#13;
      <td>0.00</td>&#13;
      <td>0.01</td>&#13;
      <td>7.05</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0601023A0AAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Acarbose 100mg tablets : 20</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=1106000AK&amp;denomIds=11.6&amp;selectedTab=summary">Tafluprost</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>41</td>&#13;
      <td>Treatment of glaucoma</td>&#13;
      <td>608</td>&#13;
      <td>0.07</td>&#13;
      <td>0.01</td>&#13;
      <td>0.01</td>&#13;
      <td>5.65</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=1106000AKAAABAB&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Tafluprost 15micrograms/ml eye drops : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=1106000AKAAAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Tafluprost 15micrograms/ml eye dps 0.3ml ud preserv free : 18</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=1106000AKBBAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Saflutan 15micrograms/ml eye drops 0.3ml unit dose : 13</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=1106000AKBBABAB&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Saflutan 15micrograms/ml eye drops : 8</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=140400050&amp;denomIds=14.4&amp;selectedTab=summary">Varicella vaccine live</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Vaccines and antisera</td>&#13;
      <td>4</td>&#13;
      <td>0.25</td>&#13;
      <td>0.00</td>&#13;
      <td>0.04</td>&#13;
      <td>5.55</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=140400050AAACAC&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Varicella vacc live inj 0.5ml vials : 1</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Park Medical Group is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0902011U0&amp;denomIds=9.2.1&amp;selectedTab=summary">Potassium chloride</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Oral potassium</td>&#13;
      <td>2</td>&#13;
      <td>0.50</td>&#13;
      <td>0.98</td>&#13;
      <td>0.12</td>&#13;
      <td>-4.04</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0902011U0BIAAAF&amp;denomIds=9.2.1&amp;selectedTab=summary" target="_blank">Sando-K effervescent tablets : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0606020A0&amp;denomIds=6.6.2&amp;selectedTab=summary">Alendronic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>338</td>&#13;
      <td>Bisphosphonates and other drugs</td>&#13;
      <td>528</td>&#13;
      <td>0.64</td>&#13;
      <td>0.87</td>&#13;
      <td>0.09</td>&#13;
      <td>-2.51</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0606020A0AAACAC&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Alendronic acid 70mg tablets : 305</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0606020A0AAAAAA&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Alendronic acid 10mg tablets : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0606020A0AAAFAF&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Alendronic acid 70mg/100ml soln unit dose sugar free : 26</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0606020A0BCAAAH&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Binosto 70mg effervescent tablets : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>68</td>&#13;
      <td>Herpes simplex and varicella-zoster</td>&#13;
      <td>86</td>&#13;
      <td>0.79</td>&#13;
      <td>0.95</td>&#13;
      <td>0.07</td>&#13;
      <td>-2.38</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0503021C0AAABAB&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg tablets : 33</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0503021C0AAAEAE&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg dispersible tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0503021C0AAAHAH&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg dispersible tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 18</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 8</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0503021C0AAAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg dispersible tablets : 7</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Antimuscarinic drugs</td>&#13;
      <td>5</td>&#13;
      <td>0.00</td>&#13;
      <td>0.82</td>&#13;
      <td>0.36</td>&#13;
      <td>-2.30</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>111</td>&#13;
      <td>Aminosalicylates</td>&#13;
      <td>340</td>&#13;
      <td>0.33</td>&#13;
      <td>0.64</td>&#13;
      <td>0.15</td>&#13;
      <td>-2.14</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0AAABAB&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg suppositories : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BCAFAT&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 2g modified-release granules sachets : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BDAIAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g suppositories : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BDAKAZ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 3g gastro-resistant modified-release gran sachets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BBAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 400mg MR gastro-resistant tablets : 14</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BDADAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 2g/59ml enema : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 3</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 12</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0AAAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 400mg gastro-resistant tablets : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BDAFAX&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g gastro-resistant modified-release gran sachets : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BHAAAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mezavant XL 1200mg tablets : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BDAEAK&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g/application foam enema : 16</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 24</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A86008&amp;numIds=0105010B0AAASAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 800mg gastro-resistant tablets : 5</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>